Abstract: A water-insoluble composition, solid in appearance at a temperature of less than or equal to 20° C., comprising, for 100% of the mass of same: —X1% by mass of at least one lipophilic surfactant having a value HLB, H1, greater than or equal to 1 and less than 10; —X2% by mass of at least one hydrophilic surfactant having a value HLB, H2, greater than or equal to 10 and less than or equal to 20; characterised by the fact that the HLB of same=X1.H1+X2.H2, X1 and X2 varying from 2 to 60, and characterised in that it is free of acrylic polymer and/or of acetate succinate.

Abstract: A water-insoluble composition, solid in appearance at a temperature of less than or equal to 20° C., comprising, for 100% of the mass of same:—X1% by mass of at least one lipophilic surfactant having a value HLB, H1, greater than or equal to 1 and less than 10;—X2% by mass of at least one hydrophilic surfactant having a value HLB, H2, greater than or equal to 10 and less than or equal to 20; characterised by the fact that the HLB of same=X1.H1+X2.H2, X1 and X2 varying from 2 to 60, and characterised in that it is free of acrylic polymer and/or of acetate succinate.

Abstract: Composition (C) for coating ingestible solid forms, comprising, per 100% of its mass—from 10% to 90% of a graft copolymer of polyvinyl alcohol and of polyethers (Pi), and—from 10% to 90% by mass of an auxiliary coating agent, characterized in that a non-zero mass proportion of said auxiliary agent is polydextrose. Processes for the preparation and use thereof.

Abstract: Composition (C) for coating ingestible solid forms, comprising, per 100% of its mass—from 10% to 90% of a graft copolymer of polyvinyl alcohol and of polyethers (Pi), and—from 10% to 90% by mass of an auxiliary coating agent, characterized in that a non-zero mass proportion of said auxiliary agent is polydextrose. Processes for the preparation and use thereof.

Abstract: A composition comprising an aqueous solution comprising: (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence, and (ii) as an adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15.

Abstract: Composition for the implementation of a therapeutic method for the human or animal body, comprising a fatty phase (O) and an aqueous phase (W), in the form of an 5 emulsion of the water-in-oil (W/O) type, in which said aqueous phase (W) comprises at least one hydrosoluble active ingredient, characterized in that said composition has a viscosity, measured at 25° C. in a 250-cm3 beaker having a diameter of about 7 cm, using a Brookfield LVT viscosimeter equipped with a No. 2 spindle turning at a speed of 30 or 60 revolutions pre minute, of less than or equal to 10 [sic] 2000 mPas, and preferably less than 200 mPas.

Abstract: A composition with no water consisting essentially of at least one fluoride-ion-generating agent and at least one viscosity modifier, characterized in that its viscosity, measured at 25° C. using a Brookfield™ LVT viscometer fitted with a No. 1 spindle rotating at a speed of 30 revolutions per minute, is between 50 and 5000 mPa·s Method for preparing the composition, dry composition and method of frosting flat glass.

Abstract: A composition comprising an aqueous solution comprising: (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence, and (ii) as an adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15.

Abstract: A composition comprising an aqueous solution comprising: (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence, and (ii) as an adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15.

Abstract: The present invention relates to novel adjuvants for vaccine compositions and said compositions comprising at least one antigen, in particular an antigen of vital, bacterial or parasitic origin and at least one adjuvant. In particular, the subject of the invention is a composition comprising a fatty phase and a nonzero quantity of an organometallic gel comprising a complex of an anionic polymer, or a mixture of different anionic polymers, with a multivalent metal cation or a mixture of different multivalent metal cations.

Abstract: Aqueous composition comprising at least one fluoride-ion-generating agent and at least one viscosity modifier, characterized in that its viscosity, measured at 25° C. using a Brookfield™ LVT viscometer fitted with a No. 1 spindle rotating at a speed of 30 revolutions per minute, is between 50 and 5000 mPa·s. Method for preparing it, dry composition and method of frosting flat glass.

Abstract: Composition, characterized in that it comprises a hydrocarbonaceous compound or a mixture of hydrocarbonaceous compounds, a nonzero proportion of one or more transition metals and a nonzero proportion of at least one slightly polar dispersing liquid fatty phase, having one or more hydrocarbonaceous chains, with an HLB of between 0.5 and 9, preferably between 4 and 9. Its process of preparation and its use as composition for filling optical fibre cables.

Abstract: A film forming composition and a method for its use. The composition is in the form of somewhat porous granules and has a bulk density of less than about 0.5 g/cm3. The composition contains a film-forming polymer, a plasticizer and an inert filler.

Abstract: A pulverulent surfactant composition and its method of use. The composition is contains a surfactant that is liquid or pasty at ambient temperature and a solid support. The composition will flow freely, such that its flow time for 100 grams of composition is less than or equal to ten seconds. The composition may be used as a solubilizing agent in tablets, gelatin capsules, chewing gums and confectionary products.

Abstract: The invention concerns the use as surfactants of inclusion complexes in the form of powder or aqueous dispersion between a cyclodextrin and a fatty substance. The invention also concerns a method for preparing an emulsion using said inclusion complexes and the emulsions obtained using said method. The invention is applicable to cosmetic, pharmaceutical, food and industrial products.

Abstract: The present invention relates to novel adjuvants for vaccine compositions and said compositions comprising at least one antigen, in particular an antigen of viral, bacterial or parasitic origin and at least one adjuvant. In particular, the subject of the invention is a composition comprising a fatty phase and a nonzero quantity of an organometallic gel comprising a complex of an anionic polymer, or a mixture of different anionic polymers, with a multivalent metal cation or a mixture of different multivalent metal cations.

Abstract: Provided is a process for etching glass objects by chemical treatment. The process includes (a) at least one stage of chemical treatment of the object, and (b) at least one stage of rinsing the objects etched by the treatment of step (a) with an aqueous solution of one or more alkali metal or alkaline earth metal cation salts.

Abstract: Use of ethers of sugars, as adjuvants of immunity in immunization compositions, therapeutic compositions containing them and the use thereof as vaccines

Abstract: Composition, characterized in that it comprises a hydrocarbonaceous compound or a mixture of hydrocarbonaceous compounds, a nonzero proportion of one or more transition metals and a nonzero proportion of at least one slightly polar dispersing liquid fatty phase, having one or more hydrocarbonaceous chains, with an HLB of between 0.5 and 9, preferably between 4 and 9. Its process of preparation and its use as composition for filling optical fiber cables.

Abstract: The present invention relates to the use of ethoxylated fatty acid esters as self-emulsifiable compounds particularly useful for the preparation of phytosanitary treatment products or as drugs for veterinary or human use. According to the invention, said fatty acid esters comprise a total number of ethylene oxide molecules such that the HLB value (hydrophilic-lipophilic balance) of said compounds is comprised between about 4 and about 10, preferably between about 5 and about 9. Said ethoxylated fatty acid esters form in an original way self-emulsifiable components without requiring any other surfactant, and they are biodegradable and capable of dissolving active principles which are little or non water-soluble.